Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

Estrogens suppress RANK ligand-induced osteoclast differentiation via a stromal cell independent mechanism involving c-jun repression.

Open access
Shevde, Nirupama K., Bendixen, Amy C., Dienger, Krista M., Pike, J. Wesley · 2000 · Proceedings of the National Academy of Sciences

Abstract

Loss of ovarian function following menopause results in a substantial increase in bone turnover and a critical imbalance between bone formation and resorption. This imbalance leads to a progressive loss of trabecular bone mass and eventually osteoporosis, in part the result of increased osteoclastogenesis. Enhanced formation of functional osteoclasts appears to be the result of increased elaboration by support cells of osteoclastogenic cytokines such as IL-1, tumor necrosis factor, and IL-6, all of which are negatively regulated by estrogens. We show here that estrogen can suppress receptor activator of NF-κB ligand (RANKL) and macrophage colony-stimulating factor (M-CSF)-induced differentiation of myelomonocytic precursors into multinucleated tartrate-resistant acid phosphatase-positive osteoclasts through an estrogen receptor-dependent mechanism that does not require mediation by stromal cells. This suppression is dose-dependent, isomer-specific, and reversed by ICI 182780. Furthermore, the bone-sparing analogues tamoxifen and raloxifene mimic estrogen's effects. Estrogen blocks RANKL/M-CSF-induced activator protein-1-dependent transcription, likely through direct regulation of c-Jun activity. This effect is the result of a classical nuclear activity by estrogen receptor to regulate both c-Jun expression and its phosphorylation by c-Jun N-terminal kinase. Our results suggest that estrogen modulates osteoclast formation both by down-regulating the expression of osteoclastogenic cytokines from supportive cells and by directly suppressing RANKL-induced osteoclast differentiation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.130200197

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 40 references

Research works printed but not linked: 11

  1. R T Turner, B L Riggs, T C Spelsberg Endocr Rev 15, 275–300 (1994).
  2. F Cosman, R Linsay Endocr Rev 20, 418–434 (1999).
  3. R G Erben, S Raith, J Eberle, M Stangassinger Am J Physiol 274, E476–E483 (1998).
  4. 10.1210/endo.139.11.6433 · doi:10.1210/endo.139.11.6433 · Paper page
  5. 10.1001/archinte.1994.00420220081009 · doi:10.1001/archinte.1994.00420220081009
  6. G L Evans, R T Turner Bone 17, 181S–190S (1995).
  7. P Angel, M Karin Biochim Biophys Acta 1072, 129–157 (1991).
  8. A Minden, M Karin Biochim Biophys Acta 1333, F85–104 (1997).
  9. J A Katzenellenbogen, B W O'Malley, B S Katzenellenbogen Mol Endocrinol 10, 119–131 (1996).
  10. K Matsuo, L Bakiri, M Yaniv, E F Wagner J Bone Miner Res 14(Sup. 1), S177, (Abstr.). (1999).
  11. J-P David, K Sabapathy, A Behrens, B Berger, K Hochedinger, O Hoffmann, E F Wagner J Bone Miner Res 14(Sup. 1), S148, (Abstr.). (1999).

Cited by

See all 502

Metadata

Authors
Shevde, N. K., Bendixen, A. C., Dienger, K. M., & Pike, J. W.
Affiliations
  • University of Cincinnati (US)
  • University of Wisconsin–Madison (US)
Venue
Proceedings of the National Academy of Sciences
Published
2000-06-27
Volume
97
Issue
14
Pages
7829-7834
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2084535197
Cited by
502
References
40
Citations by year
2026: 9 · 2025: 12 · 2024: 15 · 2023: 19 · 2022: 12 · 2021: 13 · 2020: 24 · 2019: 10 · 2018: 21 · 2017: 17 · 2016: 13 · 2015: 14 · 2014: 16 · 2013: 18 · 2012: 21
FWCI
9.51
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01DK056059, DK-56059)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
Keywords
estrogen, RANK ligand, osteoclastogenesis, c-Jun, c-Jun N-terminal kinase, estrogen receptor, macrophage colony-stimulating factor, tamoxifen, raloxifene, menopause, osteoporosis, bone resorption, fulvestrant, estrogen receptor isoforms
MeSH terms
Animals, Bone Marrow Cells, Bone Resorption, Carrier Proteins, Cell Differentiation, Cells, Cultured, Estrogens, Female, Humans, Ligands, Membrane Glycoproteins, Menopause, Osteoclasts, Ovariectomy, Receptors, Estrogen, Down-Regulation, Receptor, Macrophage Colony-Stimulating Factor, Proto-Oncogene Proteins c-jun, Stromal Cells, Receptors, Tumor Necrosis Factor, Mitogen-Activated Protein Kinases, Mitogen-Activated Protein Kinase 8, Mice, RANK Ligand, Receptor Activator of Nuclear Factor-kappa B

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Estrogens suppress RANK ligand-induced osteoclast differentiation via a stromal cell independent mechanism involving c-jun repression. https://app.cochat.ai/papers/10.1073/pnas.130200197
The paper
Shevde, N. K., Bendixen, A. C., Dienger, K. M., & Pike, J. W. (2000). Estrogens suppress RANK ligand-induced osteoclast differentiation via a stromal cell independent mechanism involving c-jun repression. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.130200197

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.